User Image Cart Icon 0 Search Image
  • Home > Blog > Fatty Liver Insulin Resistance

Fatty Liver Insulin Resistance

  1. The role of insulin resistance in nonalcoholic fatty liver disease
  2. insulin resistance in nonalcoholic fatty liver disease
  3. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
  4. Association of nonalcoholic fatty liver disease with insulin resistance
  5. Modulation of insulin resistance in nonalcoholic fatty liver disease
  6. Nonalcoholic fatty liver disease and insulin resistance : new insights and potential new treatments
  7. Nonalcoholic fatty liver disease as a complication of insulin resistance
  8. The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review
  9. insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
  10. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
  11. The fatty liver and insulin resistance
  12. insulin resistance , the metabolic syndrome, and nonalcoholic fatty liver disease
  13. insulin resistance in development and progression of nonalcoholic fatty liver disease
  14. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
  15. Nonalcoholic fatty liver disease, hepatic insulin resistance , and type 2 diabetes
  16. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines
  17. fatty liver , insulin resistance , and dyslipidemia
  18. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes
  19. Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance
  20. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
  21. Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison?
  22. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
  23. insulin resistance across the spectrum of nonalcoholic fatty liver disease
  24. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
  25. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
  26. insulin resistance , inflammation, and non-alcoholic fatty liver disease
  27. Mechanisms of insulin resistance in primary and secondary nonalcoholic fatty liver
  28. Pathogenesis of insulin resistance and atherogenic dyslipidemia in nonalcoholic fatty liver disease
  29. fatty liver —an additional and treatable feature of the insulin resistance syndrome
  30. Ectopic fat, insulin resistance , and nonalcoholic fatty liver disease: implications for cardiovascular disease
  31. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance
  32. Non-alcoholic fatty liver and insulin resistance : a cause–effect relationship?
  33. Obesity, insulin resistance , and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease
  34. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
  35. insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
  36. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease
  37. Non-alcoholic fatty liver disease in obese youth with insulin resistance and type 2 diabetes
  38. Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD)
  39. insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
  40. Non-alcoholic fatty liver disease and insulin resistance : from bench to bedside
  41. Non-alcoholic fatty liver disease, insulin resistance , metabolic syndrome and their association with vascular risk
  42. Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance
  43. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease
  44. Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths
  45. … complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance , dyslipidemia and nonalcoholic fatty liver disease
  46. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease
  47. The relationship between liver enzymes and insulin resistance in type 2 diabetes patients with nonalcoholic fatty liver disease
  48. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance : cause or consequence?
  49. fatty liver as a consequence and cause of insulin resistance : lessons from type 2 diabetic liver
  50. Nonalcoholic fatty liver disease: lipids and insulin resistance
  51. The interplay between insulin resistance , inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease
  52. Combined influence of insulin resistance , overweight/obesity, and fatty liver as risk factors for type 2 diabetes
  53. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance
  54. liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance
  55. Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease
  56. Leptin, insulin resistance , and liver fibrosis in human nonalcoholic fatty liver disease
  57. insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease
  58. Dietary composition and its association with newly diagnosed nonalcoholic fatty liver disease and insulin resistance
  59. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
  60. Nonalcoholic fatty liver disease, insulin resistance , and sweeteners: a literature review
  61. Emerging pharmacological targets for the treatment of nonalcoholic fatty liver disease, insulin resistance , and type 2 diabetes
  62. Irisin, a link among fatty liver disease, physical inactivity and insulin resistance
  63. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
  64. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease
  65. Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
  66. The emerging role of endocrine disruptors in pathogenesis of insulin resistance : a concept implicating nonalcoholic fatty liver disease
  67. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents
  68. insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a …
  69. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes
  70. fatty liver , insulin resistance , and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people
  71. fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance
  72. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical …
  73. Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance
  74. Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation
  75. Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease
  76. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
  77. Adherence to mediterranean diet and non-alcoholic fatty liver disease: effect on insulin resistance
  78. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)
  79. Nonalcoholic fatty liver disease and estimated insulin resistance in obese youth: a mendelian randomization analysis
  80. The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance
  81. Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease
  82. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects.
  83. fatty liver is associated with insulin resistance , risk of coronary heart disease, and early atherosclerosis in a large European population
  84. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance
  85. Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance , inflammation and fatty liver
  86. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects
  87. Hepatic insulin resistance is not pathway selective in humans with nonalcoholic fatty liver disease
  88. insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease
  89. Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver -targeted mitochondrial uncoupler
  90. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease
  91. Potential nexus of non-alcoholic fatty liver disease and type 2 diabetes mellitus: insulin resistance between hepatic and peripheral tissues
  92. Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies
  93. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease
  94. Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes
  95. Role of insulin resistance and diabetes in the pathogenesis and treatment of nonalcoholic fatty liver disease
  96. insulin resistance exacerbates genetic predisposition to nonalcoholic fatty liver disease in individuals without diabetes
  97. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin –resistance and endothelial dysfunction
  98. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver [S]
  99. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance , dyslipidemia, atherosclerosis and coronary heart disease
  100. insulin resistance and C‐reactive protein as independent risk factors for non‐alcoholic fatty liver disease in non‐obese Asian men
  101. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease
  102. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance
  103. insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals
  104. Hepatic insulin resistance and nonalcoholic fatty liver disease
  105. insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease
  106. Relationship between serum TNF activity and insulin resistance in dairy cows affected with naturally occurring fatty liver
  107. Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial
  108. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease
  109. Serum lipoprotein (a) levels and insulin resistance have opposite effects on fatty liver disease
  110. Resveratrol improves insulin resistance , glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial
  111. Nonalcoholic fatty liver disease and thrombocytopenia III: its association with insulin resistance
  112. fatty liver has stronger association with insulin resistance than visceral fat accumulation in nonobese Japanese men
  113. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance , and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease …
  114. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
  115. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children
  116. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population
  117. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver
  118. Predictive value of adiposity level, metabolic syndrome, and insulin resistance for the risk of nonalcoholic fatty liver disease diagnosis in obese children
  119. Recent insights into fatty liver , metabolic dyslipidaemia and their links to insulin resistance
  120. Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
  121. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene
  122. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
  123. Shifting perspectives–interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals
  124. Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease
  125. … fatty liver disease is prevalent in women with prior gestational diabetes mellitus and independently associated with insulin resistance and waist circumference
  126. Non-alcoholic fatty liver disease and insulin resistance
  127. Weight loss, insulin resistance , and study design confound results in a meta-analysis of animal models of fatty liver
  128. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome
  129. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance , adiponectin, and visceral fat
  130. The rs626283 Variant in theMBOAT7Gene is Associated with insulin resistance and fatty liver in Caucasian Obese Youth
  131. A mouse model of metabolic syndrome: insulin resistance , fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet
  132. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance : human data
  133. Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease
  134. Second World Congress on the insulin resistance Syndrome: insulin resistance syndrome and nonalcoholic fatty liver disease
  135. The association between non‐alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents
  136. Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance
  137. A case-control study on insulin resistance , metabolic co-variates & prediction score in non-alcoholic fatty liver disease
  138. Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease
  139. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome
  140. The relationship between insulin resistance and liver damage in non-alcoholic fatty liver patients
  141. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children
  142. Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics
  143. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans
  144. Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
  145. Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction
  146. Importance of insulin resistance in patients with nonalcoholic fatty liver disease and diastolic dysfunction of the heart
  147. Hemostatic alterations linked to body fat distribution, fatty liver , and insulin resistance
  148. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance
  149. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver  …
  150. Association of insulin resistance and non-alcoholic fatty liver disease
  151. Associations of serum fatty acid proportions with obesity, insulin resistance , blood pressure, and fatty liver : the cardiovascular risk in Young Finns Study
  152. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non‐alcoholic fatty liver disease
  153. Nonalcoholic fatty liver disease, insulin resistance , and ceramides
  154. Hepatic lipase activity is increased in non‐alcoholic fatty liver disease beyond insulin resistance
  155. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial
  156. Investigating the relationship between insulin resistance and fatty liver in a random population of Tehran
  157. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes
  158. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance
  159. Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans
  160. Metabolic syndrome, insulin resistance and fatty liver in obese Iranian children
  161. Causal Relationship of Non-alcoholic fatty liver Disease with Obesity and insulin resistance .
  162. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance , cortisolemia and non-alcoholic fatty liver disease indices: a double-blind …
  163. The gut‐liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance ?
  164. The effect of low glycemic index and glycemic load diets on hepatic fat mass, insulin resistance , and blood lipid panels in individuals with nonalcoholic fatty liver  …
  165. The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults
  166. Triglyceride glucose index is superior to the homeostasis model assessment of insulin resistance for predicting nonalcoholic fatty liver disease in Korean …
  167. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study
  168. Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease
  169. Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population
  170. insulin resistance , body composition, and fat distribution in obese children with nonalcoholic fatty liver disease
  171. Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease
  172. Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease
  173. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance
  174. Prevalence of fatty liver disease among type 2 diabetes mellitus patients and its relation to insulin resistance
  175. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys …
  176. Reviewing the physiological effects of aerobic and resistance training on insulin resistance and some biomarkers in non-alcoholic fatty liver disease
  177. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload
  178. Hypoadiponectinemia and insulin resistance are associated with nonalcoholic fatty liver disease
  179. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic …
  180. Ceramides: a cause of insulin resistance in nonalcoholic fatty liver disease in both murine models and humans
  181. Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance : a potential mechanism for hepatoprotection by betaine
  182. liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in J apanese patients with non‐alcoholic fatty liver disease
  183. insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients
  184. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents
  185. Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
  186. Nonalcoholic fatty liver disease (NAFLD) without insulin resistance : Is it different?
  187. Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers
  188. Maternal high-fat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver
  189. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese …
  190. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance , and waist circumference
  191. Sleep disruption and daytime sleepiness correlating with disease severity and insulin resistance in non-alcoholic fatty liver disease: a comparison with healthy …
  192. Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver
  193. Prevalence of insulin resistance in subjects with nonalcoholic fatty liver disease and its predictors in a Chinese population
  194. Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis
  195. Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
  196. The effect of pioglitazone and metformin on liver function tests, insulin resistance , and liver fat content in nonalcoholic fatty liver disease: a randomized …
  197. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease
  198. insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross …
  199. insulin resistance but not visceral adiposity index is associated with liver fibrosis in nondiabetic subjects with nonalcoholic fatty liver disease
  200. … sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance
  201. fatty liver largely explains associations of subclinical hypothyroidism with insulin resistance , metabolic syndrome, and subclinical coronary atherosclerosis
  202. Investigating the onset of insulin resistance and non-alcoholic fatty liver disease in obesity-induced cardiac dysfunction
  203. … nanocurcumin supplementation on insulin resistance , lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a …
  204. Comparison of abdominal obesity and fatty liver and their association with insulin resistance and metabolic syndrome in Chinese adults
  205. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease
  206. The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance
  207. Body fat distribution and insulin resistance : beyond obesity in nonalcoholic fatty liver disease among overweight men
  208. Upregulated lncRNA HCG18 in patients with non-alcoholic fatty liver disease and its regulatory effect on insulin resistance
  209. Relationships between estimates of adiposity, insulin resistance , and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults
  210. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease
  211. Interleukin‐32 contributes to human nonalcoholic fatty liver disease and insulin resistance
  212. Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance
  213. Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease
  214. insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients
  215. insulin resistance and non-alcoholic fatty liver disease in premenopausal women with metabolic syndrome
  216. Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markers
  217. Relationship between non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance in Korean adults: a cross-sectional study
  218. KLF10 deficiency in CD4+ T cells triggers obesity, insulin resistance , and fatty liver
  219. … fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance
  220. … homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A …
  221. Increased acylation stimulating protein concentrations in nonalcoholic fatty liver disease are associated with insulin resistance
  222. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator–activated receptor γ …
  223. Nutrient intake in Italian obese patients: relationships with insulin resistance and markers of non-alcoholic fatty liver disease
  224. Nonalcoholic fatty liver disease: prevalence, influence on age and sex, and relationship with metabolic syndrome and insulin resistance
  225. Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance ?
  226. Chronic alcohol consumption is inversely associated with insulin resistance and fatty liver in Japanese males
  227. The Association between SOCS1− 1656G> A Polymorphism, insulin resistance and Obesity in Nonalcoholic fatty liver Disease (NAFLD) Patients
  228. Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease
  229. insulin resistance and metabonomics analysis of fatty liver haemorrhagic syndrome in laying hens induced by a high-energy low-protein diet
  230. … Study of Hepatic Steatosis (fatty liver Disease) and liver Enzymes (ALT, AST, GGT) In The Scenario of insulin resistance Among Young Medicos
  231. Non-alcoholic fatty liver disease and insulin resistance : importance of risk factors and histological spectrum
  232. The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD)
  233. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance
  234. Retracted: Genistein improves liver function and attenuates non‐alcoholic fatty liver disease in a rat model of insulin resistance
  235. The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease
  236. Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects
  237. Metabolic inflexibility and insulin resistance in obese adolescents with non‐alcoholic fatty liver disease
  238. Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
  239. Effects of garlic powder supplementation on insulin resistance , oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized …
  240. Determination of metabolic syndrome and insulin resistance rate among adults with ultrasound diagnosed non-alcoholic fatty liver disease
  241. Loss of hepatic CEACAM1: a unifying mechanism linking insulin resistance to obesity and non-alcoholic fatty liver disease
  242. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population
  243. Evaluation of potential gene expression as early markers of insulin resistance and non-alcoholic fatty liver disease in the Indonesian population
  244. Association of nonalcoholic fatty liver disease with insulin resistance : is OGTT indicated in nonalcoholic fatty liver disease?
  245. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet–Induced fatty liver
  246. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults …
  247. Consumption of barley β‐glucan ameliorates fatty liver and insulin resistance in mice fed a high‐fat diet
  248. liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease
  249. Serum chemerin concentrations associate with beta-cell function, but not with insulin resistance in individuals with non-alcoholic fatty liver disease (NAFLD)
  250. Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease
  251. insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease
  252. Redox regulation of metabolic syndrome: recent developments in skeletal muscle insulin resistance and non-alcoholic fatty liver disease (NAFLD)
  253. Does diacylglycerol accumulation in fatty liver disease cause hepatic insulin resistance ?
  254. insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome
  255. Non‐alcoholic fatty liver disease and insulin resistance
  256. Factors Governing Development of Non-Alcoholic fatty liver Disease and insulin resistance in Obesity
  257. Are saturated fatty acids and insulin resistance associated with fatty liver in obese children?
  258. fatty liver , insulin resistance , and obesity: relationships with increase in coronary artery calcium over time
  259. A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet
  260. A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver  …
  261. Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment
  262. Effects of garlic powder supplementation on metabolic syndrome components, insulin resistance , fatty liver index, and appetite in subjects with metabolic syndrome: A …
  263. insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease
  264. Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori
  265. The Assessment of insulin resistance and Triglyceride/Glucose Index in Nonalcoholic fatty liver Disease.
  266. Resveratrol improves liver steatosis and insulin resistance in non-alcoholic fatty liver disease in association with the gut microbiota
  267. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with …
  268. Association between insulin resistance , metabolic syndrome and nonalcoholic fatty liver disease in Chinese adults
  269. Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies
  270. Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice
  271. A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations
  272. insulin resistance is not increased in inflammatory bowel disease patients but is related to non-alcoholic fatty liver disease
  273. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children …
  274. Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21
  275. Natural history of ROHHAD syndrome: development of severe insulin resistance and fatty liver disease over time
  276. insulin resistance increases MRI-estimated pancreatic fat in nonalcoholic fatty liver disease and normal controls
  277. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease
  278. Dorothy Hodgkin Lecture 2012* Non‐alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management
  279. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance
  280. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice
  281. … accuracy of adipose insulin resistance index and visceral adiposity index for progressive liver histology and cardiovascular risk in nonalcoholic fatty liver  …
  282. … between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non‐alcoholic fatty liver  …
  283. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty  …
  284. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease
  285. fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology
  286. Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease
  287. insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease
  288. Copper exposure association with prevalence of non-alcoholic fatty liver disease and insulin resistance among US adults (NHANES 2011–2014)
  289. insulin resistance and Metabolic Syndrome in Patients with Non-Alcoholic fatty liver Disease
  290. Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin …
  291. A study on the altered glycemic and lipid parameters and prevalence of insulin resistance in nonalcoholic fatty liver disease
  292. Association of osteoprotegerin with obesity, insulin resistance and non-alcoholic fatty liver disease in children
  293. Supplementation with a specific combination of metabolic cofactors ameliorates non-alcoholic fatty liver disease, hepatic fibrosis, and insulin resistance in …
  294. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance : association and path analyses
  295. Is there any association between high-density lipoprotein, insulin resistance and non-alcoholic fatty liver disease in obese children?
  296. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis
  297. Treating fatty liver and insulin resistance
  298. The relationship between insulin resistance , metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study
  299. Apoptosis and disease severity is associated with insulin resistance in non-alcoholic fatty liver disease
  300. Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are …
  301. Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients
  302. Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction
  303. Aged garlic extract ameliorates fatty liver and insulin resistance and improves the gut microbiota profile in a mouse model of insulin resistance
  304. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children
  305. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance
  306. insulin resistance in nonalcoholic fatty liver disease: experience from Bangladesh
  307. “Interleukin-six” As Predictor of “Non Alcoholic fatty liver Disease” among “insulin resistance Syndrome”: A study protocol
  308. The PPAR α/γ agonist saroglitazar improves insulin resistance and steatohepatitis in a diet induced animal model of nonalcoholic fatty liver disease
  309. Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism
  310. Nonalcoholic fatty liver disease: cause or consequence of insulin resistance ?
  311. The effects of Zataria multiflora Boiss.(Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance : A randomized double-blind placebo-controlled clinical …
  312. Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver  …
  313. Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance [S]
  314. Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease
  315. Nonalcoholic fatty liver disease and risk of prostatic diseases: Roles of insulin resistance
  316. Effect of Omega-3 fatty acid supplementation on inflammatory markers and insulin resistance indices in patient with type 2 diabetes and nonalcoholic fatty liver : A …
  317. Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma
  318. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver
  319. Association of PNPLA3 with non‐alcoholic fatty liver disease in a minority cohort: the insulin resistance Atherosclerosis Family Study
  320. Bile acids and insulin resistance : implications for treating nonalcoholic fatty liver disease
  321. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population
  322. insulin resistance , non-alcoholic fatty liver disease and hepatitis C virus infection
  323. Lauric acid versus palmitic acid: effects on adipose tissue inflammation, insulin resistance , and non-alcoholic fatty liver disease in obesity
  324. … glucose-waist circumference is superior to the homeostasis model assessment of insulin resistance in identifying nonalcoholic fatty liver disease in healthy …
  325. Multifocal fatty liver disease, insulin resistance and carotid atherosclerosis: exploring the interrelated relationship
  326. Lipoprotein insulin resistance index reflects liver fat content in patients with nonalcoholic fatty liver disease
  327. The Effects of resistance Training on Body and liver Fat Stores and insulin resistance in Peoples with Non-Alcoholic fatty liver Disease
  328. … effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure
  329. Association of Non-alcoholic fatty liver Disease with insulin resistance in Non-Diabetic, Normal Weight Adults
  330. A mouse model of metabolic syndrome; increase in visceral adipose tissue precedes the development of fatty liver and insulin resistance in high-fat diet-fed male KK …
  331. insulin resistance , inflammation, and nonalcoholic fatty liver disease in non-obese adults without metabolic syndrome components
  332. Long-term fatty liver -induced insulin resistance in orotic acid-induced nonalcoholic fatty liver rats
  333. Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulin otropic polypeptide responses in mice
  334. Levels of circulating adipokines and their relation with glycemic control and insulin resistance in Saudi patients with non-alcoholic fatty liver disease
  335. insulin resistance links nonalcoholic fatty liver to cardiovascular diseases
  336. Cissus quadrangularis stem alleviates insulin resistance , oxidative injury and fatty liver disease in rats fed high fat plus fructose diet
  337. Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats
  338. Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators
  339. Changes in insulin resistance index and the risk of liver fibrosis in patients with nonalcoholic fatty liver disease without diabetes: Kangbuk samsung health …
  340. Association of glypican-4 with body fat distribution, insulin resistance , and nonalcoholic fatty liver disease
  341. Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T …
  342. Association of non-alcoholic fatty liver disease (NAFLD) and insulin resistance in type 2diabetes
  343. Beneficial effects of rosuvastatin on insulin resistance , adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet
  344. Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease
  345. fatty liver and insulin resistance : not always linked
  346. TIMP3 overexpression in macrophages protects from insulin resistance , adipose inflammation, and nonalcoholic fatty liver disease in mice
  347. … coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress
  348. … of 6-months Fruit-rich Diet on liver Steatosis, liver Enzymes, insulin resistance , and Lipid Profile in Patients With Non-alcoholic fatty liver Disease: a Randomized …
  349. Hybrid training system improves insulin resistance in patients with nonalcoholic fatty liver disease: a randomized controlled pilot study
  350. insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease
  351. Increased plasma levels of asymmetric dimethylarginine in nonalcoholic fatty liver disease: relation with insulin resistance , inflammation, and liver histology
  352. COX‐2‐mediated inflammation in fat is crucial for obesity‐linked insulin resistance and fatty liver
  353. Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver , and insulin resistance in type 2 diabetic patients and …
  354. Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway
  355. Evaluation of the correlation between Non-alcoholic fatty liver disease and insulin resistance
  356. Nonalcoholic fatty liver disease and insulin resistance in youth
  357. The role of endoplasmic reticulum stress and insulin resistance in the occurrence of goose fatty liver
  358. insulin resistance in Egyptian nonalcoholic fatty liver disease patients.
  359. … between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance -modulator and fatty liver -preventer
  360. Low serum sex hormone-binding globulin associated with insulin resistance in men with nonalcoholic fatty liver disease
  361. fatty acids and insulin resistance in muscle and liver
  362. Alcohol consumption is inversely correlated with insulin resistance , independent of metabolic syndrome factors and fatty liver diseases
  363. Low levels of spexin and adiponectin may predict insulin resistance in patients with non-alcoholic fatty liver
  364. … aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver  …
  365. Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without insulin resistance
  366. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance , and fatty liver disease
  367. … approach to the prediabetic state: bone–energy homeostasis axis, clinical and etiological associations of non-alcoholic fatty liver disease and insulin resistance
  368. Considering the links between nonalcoholic fatty liver disease and insulin resistance : revisiting the role of protein Kinase C ε
  369. … index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance
  370. … stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome …
  371. Nonalcoholic fatty liver and insulin resistance among petrochemical workers
  372. Hydroxypropyl methylcellulose, a viscous soluble fiber, reduces insulin resistance and decreases fatty liver in Zucker Diabetic fatty rats
  373. Chlorogenic acid alleviates autophagy and insulin resistance by suppressing JNK pathway in a rat model of nonalcoholic fatty liver disease
  374. … effect of 12 weeks high intensity interval training and resistance training on liver fat, liver enzymes and insulin resistance in men with nonalcoholic fatty liver
  375. Hepatoprotective effect of cranberry nutraceutical extract in non-alcoholic fatty liver model in rats: Impact on insulin resistance and Nrf-2 expression
  376. Elevated whole blood viscosity is associated with insulin resistance and non‐alcoholic fatty liver
  377. Early menarche is associated with insulin –resistance and non-alcoholic fatty liver disease in adolescents with obesity
  378. Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
  379. Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: a phase 1b study
  380. insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease
  381. Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease
  382. … of the relationship between genetic and environmental risk factors associated with obesity and insulin resistance in South African patients with non-alcoholic fatty liver  …
  383. Dietary Platycodon grandiflorus Attenuates Hepatic insulin resistance and Oxidative Stress in High-Fat-Diet Induced Non-Alcoholic fatty liver Disease
  384. The state of insulin resistance in patients with nonalcoholic fatty liver and the intervention with Gankangyin
  385. The Effect of Aerobic Continuous Training on Myonectin, insulin resistance and liver Enzymes in Rats with Nonalcoholic fatty liver Disease
  386. … between endoplasmic reticulum stress and liver function, insulin resistance and vascular endothelial function in patients with non-alcoholic fatty liver disease.
  387. Black sesame seeds ethanol extract ameliorates hepatic lipid accumulation, oxidative stress, and insulin resistance in fructose-induced nonalcoholic fatty liver disease
  388. … insulin resistance and chronic low-intensity sistemic inflammation on the elasticity of the vascular wall in patients with arterial hypertension and non-alcoholic fatty liver  …
  389. A pathophysiologic approach combining genetics and insulin resistance to predict the severity of nonalcoholic fatty liver disease
  390. Effects of low glycemic index diet on insulin resistance among obese adolescent with non-alcoholic fatty liver disease: A randomized controlled trial
  391. Assessment of insulin resistance in Ultrasonographically Diagnosed Cases of Non-Alcoholic fatty liver Disease.
  392. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease
  393. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease
  394. The effect of vitamin D supplementation on insulin resistance in patients with nonalcoholic fatty liver
  395. insulin resistance and Related Factors in Non-Alcoholic fatty liver Disease (NAFLD): An Analytic Cross-Sectional Study
  396. Kukoamine A attenuates insulin resistance and fatty liver through downregulation of Srebp-1c
  397. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice
  398. Activation of proteinase 3 contributes to nonalcoholic fatty liver disease and insulin resistance
  399. Mechanism of insulin resistance and hyper-insulin emia in fatty liver .
  400. MRI-diagnosed nonalcoholic fatty liver disease is correlated to insulin resistance in adolescents
  401. Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males
  402. Non-alcoholic fatty liver disease in subjects with type 2 diabetes mellitus and non-diabetics with special reference to insulin resistance and hepatic histopathological …
  403. Metformin alleviates hepatic steatosis and insulin resistance in a mouse model of high-fat diet-induced nonalcoholic fatty liver disease by promoting …
  404. Long-term fermented soybean paste improves metabolic parameters associated with non-alcoholic fatty liver disease and insulin resistance in high-fat diet-induced …
  405. Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice
  406. fatty acid—induced inflammation and insulin resistance in skeletal muscle and liver
  407. Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice
  408. … from loquat leaf alleviates type 2 diabetes mellitus combined with nonalcoholic fatty liver disease by improving insulin resistance , oxidative stress, inflammation, and …
  409. Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver disease
  410. Integrin α1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance
  411. Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease
  412. Fenretinide ameliorates insulin resistance and fatty liver in obese mice
  413. Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes
  414. CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease
  415. … sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance
  416. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance
  417. Dipeptidyl peptidase IV inhibitor improves insulin resistance and steatosis in a refractory nonalcoholic fatty liver disease patient: a case report
  418. Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease
  419. fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction
  420. Obesity-related diseases and syndromes: insulin resistance , type 2 diabetes mellitus, non-alcoholic fatty liver disease, cardiovascular disease, and metabolic …
  421. Early microcystin-LR exposure-linked inflammasome activation in mice causes development of fatty liver disease and insulin resistance
  422. The potential role of probiotics or/and prebiotic on serum lipid profile and insulin resistance in alcoholic fatty liver disease: a double blind randomized clinical trial.
  423. insulin resistance in non-alcoholic fatty liver disease
  424. FABP4-Cre mediated expression of constitutively active ChREBP protects against obesity, fatty liver , and insulin resistance
  425. Non-alcoholic fatty liver disease: the role of insulin resistance , inflammation and the PNPLA3 I148M variant
  426. … in counteracting non‐alcoholic fatty liver disease‐related complications through modulation of dyslipidemia, insulin resistance , and inflammatory pathways
  427. High Irisin levels in nondiabetic HIV‐infected males are associated with insulin resistance , nonalcoholic fatty liver disease, and subclinical atherosclerosis
  428. Dissociation of fatty liver and insulin resistance in I148M PNPLA3 carriers: differences in diacylglycerol (DAG) FA18: 1 lipid species as a possible explanation
  429. The role of adipose triglyceride lipase in hepatic lipid metabolism, non-alcoholic fatty liver disease and insulin resistance
  430. Hemochromatosis and fatty liver disease: building evidence for insulin resistance in bottlenose dolphins (Tursiops truncatus)
  431. … E treatment impairs reactive oxygen species signaling required for adipose tissue expansion, resulting in fatty liver and insulin resistance in obese mice
  432. Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus and its relation with insulin resistance in South Gujarat Region
  433. Distinguishing nonalcoholic steatohepatitis from fatty liver : serum‐free fatty acids, insulin resistance , and serum lipoproteins
  434. Vertical sleeve gastrectomy activates GPBAR‐1/TGR5 to sustain weight loss, improve fatty liver , and remit insulin resistance in mice
  435. Effects of isomaltulose on insulin resistance and metabolites in patients with non‑alcoholic fatty liver disease: A metabolomic analysis
  436. Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice
  437. A “healthy diet–optimal sleep” lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease
  438. … evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic fatty liver  …
  439. Association of Adiponectin level with biochemical variables and insulin resistance in patients with non-alcoholic fatty liver disease in an Iranian population.
  440. GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance
  441. Dietary fatty Acids and Cardiometabolic Risk: Influence on Lipoproteins, insulin resistance and liver Fat
  442. Effect of black garlic on visceral fat, oxidative stress and insulin resistance in nonalcoholic fatty liver disease rats
  443. Non-alcoholic fatty liver disease in Asian Indians: relationship with insulin resistance , diabetes and cardiovascular risk
  444. The effects of the insulin resistance index on the virologic response to entecavir in patients with HBeAg-positive chronic hepatitis B and nonalcoholic fatty liver disease
  445. G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients
  446. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease
  447. Twenty‐five‐year trajectories of insulin resistance and pancreatic β‐cell response and diabetes risk in nonalcoholic fatty liver disease
  448. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans
  449. Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease
  450. Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome …
  451. Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease
  452. Association between gut permeability and insulin resistance : Any role for zonulin in patients with non-alcoholic fatty liver disease?
  453. Severe maternal hyperglycemia exacerbates the development of insulin resistance and fatty liver in the offspring on high fat diet
  454. Lys656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease
  455. Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease
  456. … vs vitamin E monotherapy on insulin resistance , non‐invasive indices of steatosis and fibrosis, and adipokine levels in non‐alcoholic fatty liver disease: a randomized …
  457. Impaired insulin -mediated amino acid plasma disappearance in non-alcoholic fatty liver disease: a feature of insulin resistance
  458. insulin resistance syndrome and nonalcoholic fatty liver disease
  459. Role of the hypoglycemic plant extract cleome droserifolia in improving glucose and lipid metabolism and its relation to insulin resistance in fatty liver .
  460. WISP1 promotes non‐alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling
  461. … -γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance
  462. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?
  463. Evaluation of serum xenin and ghrelin levels and their relationship with nonalcoholic fatty liver disease and insulin resistance in obese adolescents
  464. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model
  465. Effects of endoplasmic reticulum stress, liver function, insulin resistance and vascular endothelial function in patients with nonalcoholic fatty liver disease
  466. Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice
  467. Biallelic mutations in GPD1 gene in a Chinese boy mainly presented with obesity, insulin resistance , fatty liver , and short stature
  468. fatty liver and insulin resistance in the liver -specific knockout mice of mitogen inducible gene-6
  469. Reduction of sitting time has a positive effect on the decrease of insulin resistance in patients with non-alcoholic fatty liver disease
  470. … TREATMENT STRATEGIES IN PATIENTS WITH NONALCOHOLIC fatty liver DISEASE IN COMBINATION WITH insulin resistance AND TYPE 2 …
  471. Association of Serum Triglyceride-to-High-density Lipoprotein Cholesterol Ratio with insulin resistance and Non-alcoholic fatty liver Disease in Children and …
  472. The effect of Bangpungtongsungsan on insulin resistance induced by non-alcoholic fatty liver disease (NAFLD)
  473. insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease
  474. … prevents insulin resistance , hepatic inflammation, and activates autophagy associated with high-fat diet–induced fatty liver hemorrhagic syndrome in aged …
  475. … improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty  …
  476. Factors governing development of nonalcoholic fatty liver disease and insulin resistance in obesity
  477. Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease
  478. Resveratrol protects against hepatic insulin resistance in a rat’s model of non‐alcoholic fatty liver disease by down‐regulation of GPAT‐1 and DGAT 2 expression and …
  479. Tumor necrosis factor receptor 1 gain‐of‐function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model
  480. The risk for insulin resistance according to the degree of non-alcoholic fatty liver disease in Korean men
  481. Comparative Effects of the Renin–Angiotensin System Blockers on Nonalcoholic fatty liver Disease and insulin resistance in C57Bl/6 Mice
  482. Dissociation between fatty liver and insulin resistance : the role of adipose triacylglycerol lipase
  483. Role of chitinase 3-like 1 protein in the pathogenesis of hepatic insulin resistance in nonalcoholic fatty liver disease
  484. Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition …
  485. Non alcoholic fatty liver disease, insulin resistance , dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy.
  486. CETP inhibition improves HDL function but leads to fatty liver and insulin resistance in CETP-expressing transgenic mice on a high-fat diet
  487. Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver
  488. Evaluation of the correlation between non-alcoholic fatty liver disease and insulin resistance
  489. Elevated levels of serum uric acid and insulin resistance are associated with nonalcoholic fatty liver disease among prediabetic subjects
  490. Obesity potentiates development of fatty liver and insulin resistance , but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice
  491. Overexpression of superoxide dismutase 3 gene blocks high-fat diet-induced obesity, fatty liver and insulin resistance
  492. insulin resistance and metabolic syndrome in non-alcoholic fatty liver disease with normal alanine aminotransferase levels
  493. … /threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance , and nonalcoholic fatty liver disease in mice
  494. Role of-55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity
  495. Dietary (−)-Epigallocatechin-3-gallate supplementation counteracts aging-associated skeletal muscle insulin resistance and fatty liver in senescence-accelerated …
  496. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats
  497. liver ultrasound is more sensitive in assessing the severity of nonalcoholic fatty liver disease with homeostasis model assessment-insulin resistance
  498. insulin resistance AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FAT liver DISEASE IN …
  499. … of genistein supplementation on insulin sensitivity, insulin resistance , and beta cells function index in patients with non-alcoholic fatty liver disease: A randomized …
  500. Metabolic Parameter and insulin resistance in Non Alcoholic fatty liver Disease Patient Attending Tertiary Care Hospital Coastal Andhra Pradesh
  501. C-reactive protein as a marker for insulin resistance in non-alcoholic fatty liver disease in non-obese South Indian population
  502. … C virus-infected patients are ‘spared’from the metabolic syndrome but not from insulin resistance . A comparative study of nonalcoholic fatty liver disease and hepatitis …
  503. The relationship between nonalcoholic fatty liver and insulin resistance with abnormal glucose metabolism
  504. … Effect of Polyphenolic Compounds from the Mangrove Tree Rhizophora mangle L. on Non-Alcoholic fatty liver Disease and insulin resistance in High-Fat …
  505. Relationship between vitamin D, PTH and insulin resistance in the development of non-alcoholic fatty liver disease (NAFLD).
  506. Curcumin suppresses Notch‑1 signaling: Improvements in fatty liver and insulin resistance in rats
  507. High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT
  508. THE IMPORTANCE OF REGULATION DIGESTIVE SYSTEM–BRAIN INTERACTIONS ON PREVENTION insulin resistance AND fatty liver
  509. Effect of eradication of Helicobacter pylori on lipid metabolism and insulin resistance in patients with non-alcoholic fatty liver disease.
  510. insulin ‐like growth factor binding protein 7 accelerates hepatic steatosis and insulin resistance in non‐alcoholic fatty liver disease
  511. … protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A …
  512. A study of non-alcoholic fatty liver disease (NAFLD) in South African patients and analysis of candidate genes in insulin resistance and fatty acid oxidation.
  513. The impact of a nutraceutical on insulin resistance in patients with non-alcoholic fatty liver disease: a retrospective observational study
  514. … , a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of …
  515. fatty liver disease, glucose tolerance and insulin resistance in obese adolescents
  516. Prevalence of Obesity, non-alcoholic fatty liver and insulin resistance and their inter relationship among type II diabetic patients attending diabetic centre …
  517. Nonalcoholic fatty liver disease and abnormal liver function test in the health screen examinees: the relationship with insulin resistance
  518. Supplementing dietary sugar promotes endoplasmic reticulum stress-independent insulin resistance and fatty liver in goose
  519. Correlation of liver fat content with serum vitamin A level and insulin resistance in patients with nonalcoholic fatty liver disease.
  520. insulin resistance and hypothyroidism: a complex relationship in non-alcoholic fatty liver disease.
  521. Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice
  522. Combined Influence of insulin resistance , Overweight/Obesity, and fatty liver as Risk Factors for Type 2 Diabetes
  523. … of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women–a hyperinsulin emic euglycemic insulin clamp …
  524. Angiopoietin‐like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non‐alcoholic fatty liver disease patients
  525. Effect of seyoeum on obesity, insulin resistance , and nonalcoholic fatty liver disease of high-fat diet-fed C57BL/6 mice
  526. Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men
  527. 19. Nonalcoholic fatty liver disease: role of insulin resistance and genetic polymorphism
  528. Autologous subcutaneous adipose tissue transplants improve adipose tissue metabolism and reduce insulin resistance and fatty liver in diet‐induced obesity rats
  529. Genetic variants associated with obesity and insulin resistance in Hispanic boys with nonalcoholic fatty liver disease
  530. Effect of cinnamon on lipid profile, liver enzymes, insulin resistance and hs-CRP inflammatory factor in patients with nonalcoholic fatty liver disease
  531. Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats
  532. Study on the correlation of fibroblast growth factor 21 level with the obesity, lipid metabolism and insulin resistance in patients with non-alcoholic fatty liver  …
  533. … expression of adipose tissue triglyceride lipase and CGI-58 may contribute to the development of non-alcoholic fatty liver disease in patients with insulin resistance
  534. … Trapa quadrispinosa pericarp extract ameliorates high-fat diet induced non-alcoholic fatty liver disease by regulating lipid metabolism and insulin resistance  …
  535. Defective FXR-SHP Regulation in Obesity Aberrantly Increases miR-802 Expression, Promoting insulin resistance and fatty liver
  536. Imipramine accelerates nonalcoholic fatty liver disease, renal impairment, diabetic retinopathy, insulin resistance , and urinary chromium loss in obese mice
  537. … of early growth response gene-1 (EGR1) is associated with progression of nonalcoholic fatty liver disease (NAFLD) in patients with insulin resistance
  538. … free fatty acid receptor 1 (GPR40/FFAR1) are protected against conjugated linoleic acid-induced fatty liver but develop inflammation and insulin resistance in …
  539. … of a Decoction of Sucrose- and Polysaccharide-Rich Radix Astragali (Huang Qi) Ameliorated insulin resistance and fatty liver but Affected Beta-Cell …
  540. Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C> G) in the development of fatty liver
  541. The Association of Dietary Meat Type and Its Cooking Method with Non-Alcoholic fatty liver Disease and insulin resistance
  542. Enforced expression of protein kinase C in skeletal muscle causes physical inactivity, fatty liver and insulin resistance in the brain
  543. … of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-α and n-3 polyunsaturated fatty acid treatment on liver  …
  544. The antipsychotics sulpiride induces fatty liver in rats via phosphorylation of insulin receptor substrate-1 at Serine 307-mediated adipose tissue insulin resistance
  545. Glucose intolerance and insulin resistance in non-alcoholic fatty liver disease: A Hospital-based Cross-sectional Study from Southern Karnataka, India
  546. Study of the relationships between insulin resistance and the levels of serum resistin in patients with nonalcoholic fatty liver disease
  547. PKC-δ and insulin resistance in non-alcoholic fatty liver disease: Effect of vitamin D
  548. … suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver  …
  549. Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance
  550. Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin –resistance and inflammation
  551. The role of ultrasonographic hepatic artery resistive index in the diagnosis of insulin resistance in obese children with non-alcoholic fatty liver disease
  552. insulin resistance , steatohepatitis, and hepatocellular carcinoma in a new congenic strain of fatty liver Shionogi (FLS) mice with the Lepob gene
  553. … with high body mass index, the aspartate aminotransferase/alanine aminotransferase ratio and insulin resistance in Japanese patients with non-alcoholic fatty liver  …
  554. Altered hepatic gene expression profiles associated with improved fatty liver , insulin resistance , and intestinal permeability after hydroxypropyl methylcellulose (HPMC …
  555. Dyslipidemia: Relationship to insulin resistance , fatty liver , and sub-clinical atherosclerosis
  556. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver
  557. Effect of vanillic acid and exercise training on fatty liver and insulin resistance in rats: Possible role of fibroblast growth factor 21 and autophagy
  558. Lack of ClC-2 alleviates high fat diet-induced insulin resistance and non-alcoholic fatty liver disease
  559. Effect of HIIT exercises on liver fat, liver Enzymes, and insulin resistance in children and adolescents with non-al-coholic fatty liver
  560. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance
  561. Silent Gallbladder Stone Associated with Nonalcoholic fatty liver Disease in a Scenario of insulin resistance in Young Adults
  562. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator
  563. Hepatocyte-specific deletion of ERK5 worsens insulin resistance in a murine model of non-alcoholic fatty liver disease (NAFLD)
  564. Non-alcoholic fatty liver disease and malignancy as complications of insulin resistance
  565. … of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin , insulin resistance , and …
  566. Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance ?
  567. … , the n-butanol soluble fraction of polygoni cuspidati rhizoma et radix, attenuates obesity, non-alcoholic fatty liver , and insulin resistance Via inhibitions of …
  568. Association of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION study
  569. Dyslipidemia: Relationship with insulin resistance , fatty liver , and Subclinical Atherosclerosis
  570. Insight into the role of Dual Specificity Phosphatase 3 in non-alcoholic fatty liver disease and insulin resistance
  571. Different susceptibility to insulin resistance and fatty liver depending on the combination of TNF-α C-857T and adiponectin G+ 276T gene polymorphisms in Japanese …
  572. Deepure tea improves high fat diet-induced insulin resistance and nonalcoholic fatty liver disease
  573. Influence of electroacupuncture on insulin –resistance in nonalcoholic fatty liver rats
  574. … -term vitamin E treatment impairs reactive oxygen species signaling required for adipose tissue expansion, resulting in fatty liver and insulin resistance in obese mice
  575. Nonalcoholic fatty liver disease and hyperuricemia: a close relation with hepatic insulin resistance after nicotinic Acid treatment?
  576. The relationship of leptin and adiponectin with insulin resistance in nonalcoholic fatty liver disease
  577. The fructose–copper connection: Added sugars induce fatty liver and insulin resistance via copper deficiency
  578. The increased activity of liver lysosomal lipase in nonalcoholic fatty liver disease contributes to the development of hepatic insulin resistance
  579. Evaluation of microRNA-34a as a molecular link between insulin resistance and nonalcoholic fatty liver disease.
  580. insulin resistance , LIPID METABOLISM AND ANTIOXIDANTS IN OBESE AND NON-OBESE CHILDREN WITH NON-ALCOHOLIC fatty liver DISEASE
  581. Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults
  582. Obesity and insulin resistance in patients with non-alcoholic fatty liver disease diagnosed by non invasive diagnostic methods
  583. … VITAMIN D SUPPLEMENTATION ON BLOOD SUGAR AND DIFFERENT INDICES OF insulin resistance IN PATIENTS WITH NON-ALCOHOLIC fatty liver  …
  584. Effects of quercetin on serum levels of resistin and IL-18 and on insulin resistance in nonalcoholic fatty liver disease rats
  585. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver
  586. Effect of alkaloids from nelumbinis plumula against insulin resistance of high-fat diet-induced nonalcoholic fatty liver disease in mice
  587. Association of genetic non-alcoholic fatty liver disease with insulin resistance -are we different?
  588. insulin resistance is a predictive factor for MRI-diagnosed non-alcoholic fatty liver disease in obese and eutrophic
  589. Elevated fasting plasma C‐peptide occurs in non‐diabetic individuals with fatty liver , irrespective of insulin resistance
  590. Roles of MicroRNA-21 in the pathogenesis of insulin resistance and diabetic mellitus-induced non-alcoholic fatty liver disease
  591. Correlation of liver fat content with serum vitamin A level and insulin resistance in patients with nonalcoholic fatty liver disease
  592. A high dose of conjugated linoleic acid increases fatty liver and insulin resistance in lactating mice
  593. O-14 A synergistic effect of PNPLA3 gene polymorphism and insulin resistance increases the risk to non-alcoholic fatty liver disease in patients with polycystic …
  594. … of cholecalciferol on the serum levels of vitamin D, adiponectin, insulin resistance , and liver function in women with non-alcoholic fatty liver disease (NAFLD): a …
  595. Predictive value of surrogate indexes of insulin resistance in evaluating non-alcoholic fatty liver disease and advanced liver fibrosis in patients with type 2 diabetes …
  596. Association of keratin 8/18 variants with non-alcoholic fatty liver disease and insulin resistance in Chinese patients: A case-control study
  597. Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content
  598. Could fatty liver Be the Major Cause of insulin resistance , Metabolic Syndrome, and Coronary Atherosclerosis in Subclinical Hypothyroidism?
  599. Effect of supplementation with calcitriol versus cholecalciferol on insulin resistance in patients with nonalcoholic fatty liver disease: Several issues of concern
  600. Effect of Nigella sativa tablets on various parameters of insulin resistance syndrome in fatty liver disease in Peshawar cantonment
  601. Experimental Research of the Relationship between insulin resistance and Non-alcoholic fatty liver Disease
  602. The relationship between nonalcoholic fatty liver disease and insulin resistance
  603. Correction to: A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
  604. Mechanism analysis of microRNA-27b causing the fatty liver formation and insulin resistance at the same onset: 1124
  605. insulin resistance (1R) but not reduced insulin secretion (IS) is associated to non alcoholic fatty liver disease (NAFLD)
  606. P0038 PP NON ALCOHOLIC fatty liver AND insulin resistance IN OBESE ADOLESCENTS
  607. insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.
  608. The relationship between insulin resistance and adiponectin gene expression in nonalcoholic fatty liver disease
  609. Association of insulin resistance with alanine aminotransferase activity in patients with nonalcoholic fatty liver disease
  610. Murine gamma herpes virus 68 infection promotes fatty liver formation and hepatic insulin resistance in C57BL/6J mice
  611. Evaluation of effect of helicobacter pylori treatment on insulin resistance in patients with nonalcoholic fatty liver disease
  612. … of Two Different Intensities of Combined Training on C1q/TNF-Related Protein 3 (CTRP3) and insulin resistance in Women with Non-alcoholic fatty liver  …
  613. The role of adipokines in the pathogenesis of non-alcoholic fatty liver disease in obese children; the relationship between body fat distribution and insulin resistance
  614. … Time Intervention (NIFTI): Fasting without calorie restriction improves hepatic transient elastography, visceral adiposity and insulin resistance compared to standard …
  615. … IN EARLY DIAGNOSIS OF THE METABOLIC MYOCARDIAL DISORDERS IN insulin resistance PATIENTS WITH NON-ALCOHOLIC fatty liver  …
  616. Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance : similarities and differences; differential approach to therapy
  617. Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease
  618. Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease
  619. Hybrid Training System Improves insulin resistance in Patients with Nonalcoholic fatty liver Disease: A Randomized Controlled Pilot Study
  620. Non-alcoholic fatty liver , high sensitivity C reactive protein and insulin resistance
  621. insulin resistance , auto-antibodies, and nonalcoholic fatty liver disease response to letter
  622. Enhancement in liver SREBP-1c/PPAR-α ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty  …
  623. Role of Tumor Necrosis Factor- Promoter Polymorphism and insulin resistance in the Development of Non-alcoholic fatty liver Disease in Obese Children
  624. The relationship between nonalcoholic fatty liver disease and insulin resistance
  625. … and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance , dyslipidemia and nonalcoholic fatty liver  …
  626. The Role of Plasminogen Activator Inhibitor-1 in Hepatic Steatosis, Dyslipidemia, insulin resistance and Fructose Consumption in Children with fatty liver Disease
  627. Effects of 12 weeks high intensity interval training on plasma Adiponectin, Leptin and insulin resistance in obese males with non-alcoholic fatty liver
  628. … IMPROVES HISTOLOGY OF NONALCOHOLIC fatty liver DISEASES INDEPENDENTLY FROM THE insulin resistance : A RANDOMIZED, CONTROLLED …
  629. 210-LB: Exploring Mechanisms of insulin resistance in Mental Illness: Antipsychotic Drugs Alter Metabolic, Inflammatory, and Nonalcoholic fatty liver Disease …
  630. Endothelial dysfunction and insulin resistance –the components of development of cardiovascular complications patients with nonalcoholic fatty liver disease
  631. Inflammation and insulin resistance as subjects for prevention and treatment of nonalcoholic fatty liver disease
  632. 2953 A Novel Tool to Estimate Early insulin resistance and Prevent Metabolic Syndrome and Non-Alcoholic fatty liver Disease: Retrospective Study in the Veteran …
  633. insulin resistance and non-alcoholic fatty liver disease induced by conjugated linoleic acid in humans
  634. Prevalence of small intestinal bacterial overgrowth (SIBO) and insulin resistance in both obese and non obese non-alcoholic fatty liver disease (NAFLD) patients
  635. Hepatitis C, insulin resistance and fatty liver : Bad things come in threes
  636. Effect of Gardenia Jasminoides on insulin resistance induced by non-alcoholic fatty liver disease
  637. Effects of GPR81 agonist on insulin resistance in rats with nonalcoholic fatty liver disease
  638. fatty liver disease, insulin resistance and adiponectin in an obese pediatric population
  639. Changes in intestinal flora in nonalcoholic fatty liver disease: their correlation with insulin resistance index, tumor necrosis factor-α, and interleukin-6
  640. The Efficacy of Ephedra sinica, Panax ginseng, and Alisma orientale Extract on insulin resistance induced by Non-alcoholic fatty liver disease (NAFLD)
  641. fatty liver -Seat of insulin resistance
  642. … the plasma levels of retinol-binding protein 4 and its relationship with insulin resistance and hepatic fat content in postmenopausal women with nonalcoholic fatty liver  …
  643. Relationship between insulin resistance , incidence of fatty liver and serum ferritin level in adults with simple obesity
  644. Risk of severe liver disease in nonalcoholic fatty liver disease: Role of insulin resistance
  645. The fatty acid synthase inhibitor platensimycin improves insulin resistance without inducing liver steatosis in mice and monkeys
  646. Effect of Artemisia capillaries Thunb on fatty liver rats with insulin resistance
  647. Regulatory Effect of Modified Banxia Xiexintang on insulin resistance of Patients with Nonalcoholic fatty liver
  648. Electroacupuncture treats rat non-alcoholic fatty liver by blocking insulin resistance and peroxidation
  649. … insulin resistance , glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial” by Shihui Chen et al.[Dig. liver Dis …
  650. A new form of insulin resistance with growth retardation, fatty liver , and hypogonadotropic hypogonadism
  651. Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population
  652. Serum and hepatic sphingolipids relate to insulin resistance , hepatic mitochondrial capacity and oxidative stress in non-alcoholic fatty liver disease
  653. Aryl hydrocarbon receptor–fibroblast growth factor 21 dissociation of fatty liver from insulin resistance : A timely matter?
  654. The Response of Some Hepatokines and insulin resistance to High Intensity Interval Training In Women with Non-Alcoholic fatty liver
  655. Interaction between insulin resistance and common variants for non-alcoholic fatty liver disease
  656. insulin resistance and Genetic Risk Predict liver ‐Related Outcomes and Death in Nonalcoholic fatty liver Disease
  657. Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease
  658. Wheat bran with unbound ferulic acid does not alter obesity, insulin resistance or fatty liver in obese rats compared to wheat bran with bound ferulic acid (829.22)
  659. fatty liver , irrespective of ethnicity, is associated with reduced insulin clearance and insulin resistance in obese youths
  660. Clinical effect of oxymatrine combined with metformin on insulin resistance and serum TNF-α in patients with non-alcoholic fatty liver
  661. Effect of emodin on insulin resistance and leptin in rat with nonalcoholic fatty liver disease
  662. Augmented Fasting Beta-Cell Secretion, and not Only insulin resistance , Is a Feature of Non-Diabetic Individuals with fatty liver .
  663. Correction: The potential role of probiotics or/and prebiotic on serum lipid profile and insulin resistance in non-alcoholic fatty liver disease: A double blind randomized …
  664. … hyperglycemia in Zucker diabetic fatty rats with an SGLT2 inhibitor restores glucose effectiveness in the liver and reduces insulin resistance in skeletal muscle
  665. Non-alcoholic fatty liver disease and insulin resistance are associated with increased cardiac oxidative stress in mice
  666. Pathogenic mechanism associated with insulin resistance and adiponectin abnormality in carotid atherosclerosis patients complicated with nonalcoholic fatty liver  …
  667. Ceramides Dissociate Steatosis and insulin resistance in the Human liver in Non-Alcoholic fatty liver Disease
  668. The effect of LXRα, ChREBP and Elovl6 in liver and white adipose tissue on medium-and long-chain fatty acid diet-induced insulin resistance
  669. insulin resistance AS A RISK FACTOR FOR HYPERTENSIVE PATIENTS WITH NON-ALCOHOLIC fatty liver DISEASE: 7C. 04
  670. New metabolic index in the diagnosis of insulin resistance in patients with nonalcoholic fatty liver disease
  671. Plasma adiponectin in non alcoholic fatty liver disease is related to hepatic insulin resistance and hepatic fat content
  672. Effect of Qianggan capsules on insulin resistance index and liver fibrosis score in patients with nonalcoholic fatty liver disease
  673. Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease
  674. GW29-e0215 Long-term exercise alleviates non-alcoholic fatty liver disease and insulin resistance via regulating lipid metabolism in ApoE-null mice
  675. Young Adult LEW. 1WR1 Rats, a Model of liver FAT10 Overexpression, Develop insulin resistance and fatty liver With Age
  676. Correlation between plasma fibroblast growth factor 21 level, obesity and insulin resistance in nonalcoholic fatty liver disease patients.
  677. Visceral fat evaluated by ultrasound is associated with insulin resistance and liver damage in patients with non-alcoholic fatty liver disease
  678. Protecting actions of Peristrophe roxburghiane on liver functions and structure in fatty liver rats caused by insulin resistance
  679. Effect of curcumin on hepatic 11β-HSD1 expression and insulin resistance in rats with nonalcoholic fatty liver disease
  680. VERSION for Article in Press E00017-2006-R1 insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease
  681. Elevated hepatic DPP4 causes fatty liver and insulin resistance
  682. … model assessment of insulin resistance and lobular inflammation in nondiabetic patients with nonalcoholic fatty liver disease: methodological considerations
  683. Possible roles of insulin , glucagon, growth hormone and free fatty acids in the pathogenesis of insulin resistance of subjects with chronic liver diseases
  684. 2111: insulin resistance patterns over 25-years of adulthood and nonalcoholic fatty liver disease in middle age: The Coronary Artery Risk Development in Young …
  685. … Combined with Neuromuscular Electrical Stimulation on liver Stiffness and insulin resistance in Patients with Non-alcoholic fatty liver Disease: An Exploratory …
  686. Effect of the hepatic extracellular vesicles in inflammation-associated insulin resistance in non-alcoholic fatty liver disease
  687. … overload induces visceral adipose tissue insulin resistance and hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin resistance
  688. Non-alcoholic fatty liver disease (NAFLD) in relation to insulin resistance , metabolic syndrome and obesity.
  689. Evaluation of sonogeraphic index for insulin resistance and metabolic syndrome in asymptomatic fatty liver disease
  690. Assessment of thyroid functions, thyroid autoimmunity and insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease
  691. Association between mid-upper arm circumference and non-alcoholic fatty liver disease or insulin resistance in middle-aged and elderly Chinese community …
  692. Association of ApoB/ApoA-1 Ratio with insulin resistance in Patients with Non-alcoholic fatty liver Disease
  693. The relevance of fatty liver and insulin resistance
  694. insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
  695. Nonalcoholic fatty liver Disease (NAFLD) Without insulin resistance : Is it Different?
  696. Association between non alcoholic fatty liver disease and the insulin resistance metabolic syndrome
  697. Study of relation between insulin resistance and fatty liver in type 2 diabetes and clinical effect of Yiqi Yangyin and Huoxue prescription.
  698. Non-alcoholic fatty liver disease in patients attending the National Severe insulin resistance Service
  699. The relationships between the changes of liver enzymes and changes of insulin resistance , C-reactive protein in patients with non-alcoholic fatty liver
  700. QS95. insulin resistance Is A Predictor for Presence of and Grade of Inflammation in Non-Alcoholic fatty liver Disease
  701. The unity of pathogenesis of insulin resistance syndrome and non-alcoholic fatty disease of liver . The metabolic disorder of fatty acids and triglycerides
  702. Alleles c282y and h63d hfe gene, insulin resistance and susceptibility to disturbance of porphyrin metabolism in non-alcoholic fatty liver disease
  703. insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease
  704. PROGRESSION OF NON-ALCOHOLIC fatty liver DISEASE AND insulin resistance IN liver , MUSCLE AND ADIPOSE TISSUES OF MORBID OBESE …
  705. liver Fat and insulin resistance as Major Determinants of Plasma Alanine Aminotransferase Levels in Nonalcoholic fatty liver Disease: 824
  706. Serum ALT is an Independent Predictor of Metabolic Syndrome and insulin resistance in Patients of Non-alcoholic fatty liver Disease
  707. Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats
  708. Association between serum preptin level and insulin resistance in patients with nonalcoholic fatty liver disease
  709. Determination of plasma resistin level and correlation with insulin resistance in patients with nonalcoholic fatty liver .
  710. Twentyâ fiveâ year trajectories of insulin resistance and pancreatic βâ cell response and diabetes risk in nonalcoholic fatty liver disease
  711. Serum ALT Is an Independent Predictor of Metabolic Syndrome and insulin resistance in Patients of Non-alcoholic fatty liver Disease: 906
  712. Systemic administration of siRNA targeting SREBP2 attenuates non-alcoholic fatty liver disease, inflammation and insulin resistance
  713. Differential contribution of peripheral and hepatic insulin resistance to histological features in patients with non alcoholic fatty liver disease: 1525
  714. Effects of Dendrobium nobile Lindl. alkaloids on insulin resistance in diabetic rats with non-alcoholic fatty liver disease
  715. insulin resistance AND liver FIBROSIS IN VIRUS C CHRONIC HEPATITIS AND IN NONALCOHOLIC fatty liver DISEASE: 313
  716. Dysregulation of miR-129-5p in Patients with Non-Alcoholic fatty liver Disease and Its Regulatory Effect on insulin resistance
  717. GW24-e1277 Increased risk of nonalcoholic fatty liver disease in women with polycystic ovary syndrome related to insulin resistance
  718. Prevention of CLA-induced insulin resistance and Nonalcoholic fatty liver Disease by Docosahexaenoic Acid in Mice
  719. Atherogenic Dyslipidemia in the Setting of insulin resistance Contributes to Cardiovascular Risk in Patients with Nonalcoholic fatty liver Disease: 856
  720. Gall stones in non-alcoholic fatty liver disease and its relation to insulin resistance and apolipoprotein-B
  721. Protective effects of fenofibrate on insulin resistance in mice of nonalcoholic fatty liver disease and its partly mechanisms of action
  722. MEASUREMENT OF insulin resistance BY QUCKI CAN PREDICT THE DEGREE OF FIBROSIS IN NON ALCOHOLIC fatty liver DISEASE (NAFLD): 295
  723. SITES OF insulin resistance IN OBESE NON-DIABETIC SUBJECTS WITH NON-ALCOHOLIC fatty liver DISEASE (NAFLD): 989
  724. Increased cardiac oxidative stress in a mouse transgenic model of non-alcoholic fatty liver disease and insulin resistance
  725. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics
  726. Vitamin D levels in Nonalcoholic fatty liver Disease associate with insulin resistance and liver progression via a Novel NLG4 dependent NK recognition: 111
  727. Research Article insulin resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic fatty liver Disease and Normal Controls
  728. A choline deficient diet in mice prevents high fat diet induced insulin resistance in spite of more severe fatty liver disease
  729. Relationship between serum protein kinase Cε activity and insulin resistance in elderly patients with concurrent type 2 diabetes mellitus and non-alcoholic fatty liver  …
  730. insulin resistance (IR) AND TYPE II DIABETES (DM) ARE INDEPENDENT PREDICTORS OF OVERALL AND liver -RELATED MORTALITY IN NON …
  731. The role of adiponectin, insulin resistance , and vitamin D as predictors of transformation of fatty liver to hepatocellular carcinoma
  732. Relationship between adiponectin and hepatic fibrosis markers expressions as well as insulin resistance index in patients with non-alcoholic fatty liver disease
  733. Plasma adiponectin in non alcoholic fatty liver disease is related to hepatic fat content and hepatic insulin resistance , not to liver disease severity
  734. Effect of Yiqi Yangyin Huoxue principle on insulin resistance and serum leptin level in patients with type 2 diabetes mellitus combined with fatty liver disease.
  735. Circulating resistin levels are not associated with insulin resistance or metabolic profile in children with non-alcoholic fatty liver disease
  736. … of peripheral and hepatic insulin resistance and evaluation of their utility as non-invasive predictors of histological features in patients with Non-Alcoholic fatty liver  …
  737. … between Hepatic and Adipose Tissue insulin resistance with liver Fibrosis in Patients with Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic fatty liver Disease …
  738. High Incidence of fatty liver and insulin resistance in Long-Term Adult Survivors of Childhood Stem Cell Transplantation Recipients.
  739. Dissociation of Hepatic insulin resistance with Severity of Steatosis in Diet-Induced Mice Model of Nonalcoholic fatty liver Disease: 722
  740. Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver 1 disease induced by a high fat and high carbohydrate diet in mice 2
  741. MRI-estimated pancreatic fat is associated with insulin resistance and is greater in patients with non-alcoholic fatty liver disease than healthy controls: 1557
  742. Effect of omega-3 fatty acids on t10, c12-conjugated linoleic acid induced insulin resistance , non alcoholic fatty liver disease and tissue fatty acid composition
  743. Effect of Xiaoyuhuatan decoction on insulin resistance of nonalchoholic fatty liver disease rat
  744. TIGAR is an insulin -regulated bisphosphatase that promotes hepatic insulin resistance and ChREBPβ-mediated steatosis in the fatty liver : 680
  745. 422-P: Association between Nonalcoholic fatty liver Disease and Diastolic Myocardial Dysfunction and Myocardial insulin resistance in Patients with Type 2 …
  746. Obesity and insulin resistance in nonalcoholic fatty liver
  747. Empirical study of flavone from hawthorn biloba in preventing and treating insulin  resistance and fatty liver in rats (Chinese)
  748. “fatty liver cells exhibit abnormal volume regulation and purinergic signaling: a mechanism contributing to insulin resistance ”: 252
  749. Evaluation of sonogeraphic index for insulin resistance and metabolic syndrome in asymptomatic fatty liver disease
  750. The association of atherosclerosis and combination of fatty liver , insulin resistance and obesity
  751. Differential relationships between basal and post-load insulin resistance indices and hepatic fibrosis in chronic hepatitis C and in non-alcoholic fatty liver disease
  752. Serum levels of apoptosis inhibitor of macrophage (AIM) are associated with hepatic fibrosis and insulin resistance in patients with nonalcoholic fatty liver disease: 834
  753. … ELECTRICAL MUSCLE CONTRACTIONS IMPROVES NONALCOHOLIC fatty liver DISEASE AND REDUCES insulin resistance AND INTERLEUKIN-6 …
  754. Non-alcoholic fatty liver disease and the myocardial remodeling: the role of insulin resistance in the hepatocardial association development
  755. 725 THE CHANGE OF insulin resistance IN CHRONIC HEPATITIS PATIENTS WITH NON ALCOHOLIC fatty liver DISEASE: A FIVE YEAR …
  756. MTHFR 1298 A> C gene polymorphism is associated with Non‐Alcoholic fatty liver Disease (NAFLD) and insulin resistance in well‐nourished patients
  757. … Effect of Polyphenolic Compounds from the Mangrove tree Rhizophora mangle L. Improving Non-Alcoholic fatty liver Disease and insulin resistance in High-Fat …
  758. … Spectroscopy Uncovers Important Atherogenic Lipoprotein Abnormalities in Nonalcoholic fatty liver Disease: The insulin resistance Atherosclerosis Study (IRAS).
  759. The relationship of adiponectin with insulin resistance in nonalcoholic fatty liver disease.
  760. Relationship between nonalcoholic fatty liver disease and insulin resistance in hypertensive patients
  761. … Physiology/Pathophysiology: CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver  …
  762. … -likepeptide 1 receptor agonist modulation of insulin resistance and hepatic oxidative stress in rats with diabetes mellitus combined with nonalcoholic fatty liver  …
  763. Improving Effect of Safflor Yellow on fatty liver and insulin resistance in Obese Mice
  764. 9.3 Non-alcoholic fatty liver Disease, Adiponectin and insulin –resistance In Dipper And Non-Dipper Essential Hypertensive Patients
  765. … time intervention (NIFTI): Fasting without calorie restriction improves hepatic transient elastography, visceral adiposity and insulin resistance compared to standard …
  766. … Extract of Syzygium cumini Leaf Reduces Non‐alcoholic fatty liver Disease in MSG‐obese Mice by a Joint Action on insulin resistance and Endoplasmic Reticulum …
  767. insulin resistance , the metabolic syndrome, and nonalcoholic fatty liver disease
  768. The relationship between non-alcoholic fatty liver disease and insulin resistance
  769. Impaired Shedding of TNF Receptor 1 Aggravates High Fat Diet Induced Non-Alcoholic fatty liver Disease But Does Not Cause insulin resistance in Mice: 251
  770. Non-alcoholic fatty liver disease and its association with insulin resistance in an obese population
  771. The link between insulin resistance , dyslipidaemia and fatty liver
  772. Reply to Correspondence HEP-15-1008 “AHR-FGF21 dissociation of fatty liver from insulin resistance : a timely matter?”
  773. Altered fatty Acid and Mitochondrial Metabolism in the liver of Pregnant Adiponectin‐Deficient Mice Contributes to insulin resistance and Gestational Diabetes …
  774. fatty liver , insulin resistance , and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people.
  775. insulin resistance and hypothyroidism: a complex relationship in non-alcoholic fatty liver disease.
  776. Relationship between adipocyte fatty acid-binding protein and insulin resistance in patients with fatty liver
  777. Non-alcoholic fatty liver disease, insulin resistance , metabolic syndrome and their association with vascular risk
  778. … acid (DHA) prevents trans‐10, cis‐12 conjugated linoleic acid (CLA)‐induced insulin resistance (IR) and non‐alcoholic fatty liver disease (NAFLD) but not adipose …
  779. Transient increase in mitochondrial oxidative capacity during the development of insulin resistance in a mouse model of non-alcoholic fatty liver
  780. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver
  781. Effect of insulin resistance on fatty liver in high-fat diet-fed mice
  782. The Effect of Aerobic Exercise on Attenuates of High-Fat Diet-Induced Nonalcoholic fatty liver , insulin resistance and Epicardial Fat Mass in Male Wistar Rat
  783. insulin resistance : cross-talk between adipose tissue and skeletal muscle, through free fatty acids, liver X receptor, and peroxisome proliferator-activated receptor-α …
  784. insulin resistance and related factors in non-alcoholic fatty liver disease [NAFLD]: an analytic cross-sectional study
  785. insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in patients with Non Alcoholic fatty liver Disease …
  786. A study on the altered glycemic and lipid parameters and prevalence of insulin resistance in nonalcoholic fatty liver disease.
  787. insulin resistance Traits but Not Cardiometabolic Dyslipidemia Interact With PNPLA3-rs738409 G-allele to Exacerbate Nonalcoholic fatty liver Disease
  788. Cirrhosis and fatty liver disease associated with insulin resistance in a Bull terrier.
  789. Hepatic Mitochondrial Remodeling is Mechanistically Linked to insulin resistance in Nonalcoholic fatty liver Disease
  790. Metabolic characteristic and insulin resistance in newly diagnosed type 2 diabetes patients with nonalcoholic fatty liver disease
  791. Effects of Huatan Xiezhuo Recipe on insulin resistance and leptin in rats with fatty liver
  792. Severe nonalcoholic fatty liver disease in a young woman with polycystic ovary syndrome and insulin resistance : case report
  793. Peripheral and hepatic insulin resistance are key determinants of progression of non-alcoholic fatty liver disease severity independent of body fat percentage
  794. Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic fatty liver Disease
  795. Nonalcoholic fatty liver Disease Is Associated with insulin resistance and Metabolic Syndrome in Majority of Indian Patients: 374
  796. … A HEPATOPROTECTIVE EFFECT VIA ALTERATION OF REGULATORY T CELLS DISTRIBUTION AND ALLEVIATES insulin resistance AND fatty liver  …
  797. A higher dietary intake of phenolic acids is protective against insulin resistance and non-alcoholic fatty liver disease
  798. SURROGATE MARKERS OF insulin SENSITIVITY/resistance IN PATIENTS WITH NONALCOHOLIC fatty liver DISEASES AND CHRONIC …
  799. Association of insulin resistance with alanine aminotransferase activity in patients with nonalcoholic fatty liver disease
  800. Study of inflammations’ markers and insulin resistance in obese children and adolescents with and without non-alcoholic fatty liver disease.
  801. Effect of Whole Wheat and its Fractions on Adiposity, insulin resistance , and fatty liver
  802. Association of nonalcoholic fatty liver disease with insulin resistance and dyslipidemia in patients with type 2 diabetes mellitus
  803. Combined influence of insulin resistance , overweight/obesity, and fatty liver as risk factors for type 2 diabetes.
  804. … ABUNDANCE OF STEAROYL-COA DESATURASE 1 (SCD1) MRNA AND IMPAIRED liver PROTEIN DIMERIZATION INDEPENDENTLY OF insulin resistance  …
  805. insulin resistance (IR) and non-alcoholic fatty liver disease (NAFLF) in obese paediatric patients.
  806. The role of endoplasmic reticulum stress and insulin resistance in the occurrence of goose fatty liver .
  807. insulin resistance , body composition, and fat distribution in obese children with nonalcoholic fatty liver disease.
  808. insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.
  809. Relationship between the plasma resistin, obesity and insulin resistance in nonalcoholic fatty liver disease patients
  810. insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in non-diabetic, non-dyslipidemic, normotensive patients with …
  811. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease.
  812. Secretory status of pancreas and pathogenesis of insulin resistance in rat with nonalcoholic fatty liver disease
  813. Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver .
  814. … ON LIPID PROFILE, liver ENZYMES, insulin resistance AND HS-CRP INFLAMMATORY FACTOR, IN PATIENTS WITH NONALCOHOLIC fatty liver  …
  815. Comparison of abdominal obesity and fatty liver and their association with insulin resistance and metabolic syndrome in Chinese adults.
  816. Deepure tea improves high fat diet-induced insulin resistance and nonalcoholic fatty liver disease.
  817. Triglyceride Glucose-Waist Circumference Better Identifies Nonalcoholic fatty liver Disease than Other Indices of insulin resistance in Healthy Subjects
  818. IMPACT OF insulin resistance ON THE DEVELOPMENT OF NON-ALCOHOLIC fatty liver DISEASE AND ARTERIAL HYPERTENSION IN PATIENTS WITH …
  819. Effects of Yiqi Yangyin Formula on insulin resistance of rats with non-alcoholic fatty liver disease.
  820. < The> association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children
  821. insulin resistance , prediabetes and type 2 diabetes melitus in early forms of non-alcoholic fatty liver disease
  822. 4. Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without insulin resistance
  823. Effect of Seyoeum on obesity, insulin resistance , and nonalcoholic fatty liver disease of high-fat diet-fed C57BL/6 mice.
  824. 6. Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without insulin resistance
  825. Tumour necrosis factor-[alpha] and insulin resistance in patients with nonalcoholic fatty liver disease in combination with type 2 diabetes mellitus
  826. Iron contributes to hepatocyte insulin resistance in a cell model of nonalcoholic fatty liver disease
  827. Abstract P141: Non-alcoholic fatty liver Disease, insulin resistance , and the Risk of Incident Ischemic Heart Disease and Stroke-The Kangbuk Samsung Health …
  828. Body fat distribution and insulin resistance : beyond obesity in nonalcoholic fatty liver disease among overweight men.
  829. Low vitamin D status is closely associated with nonalcoholic fatty liver disease in the subjects with diabetes or insulin resistance
  830. … of Modified Taohe Chengqitang Combined with Colon Hydrotherapy on Inflammatory Factors and insulin resistance in Patients with Severe Nonalcoholic fatty liver  …
  831. Determination of plasma resistin level and correlation with insulin resistance in patients with nonalcoholic fatty liver .
  832. Intrauterine Growth Retardation, insulin resistance , and Nonalcoholic fatty liver Disease in Children: Response to Fraser et al.
  833. Effects of berberine on insulin resistance and serum adiponectin of nonalcoholic fatty liver patients.
  834. fatty liver and whole-body insulin resistance relate to myocardial lipotoxicity
  835. â healthy dietâ optimal sleepâ lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease
  836. Correlation study of serum uric acid and insulin resistance in type 2 diabetes patients with non-alcoholic fatty liver disease
  837. The study of relationship between insulin resistance and dyslipidemia in type 2 diabetes associated with nonalcoholic fatty liver
  838. Gut permeability is related to body weight, fatty liver disease and insulin resistance in obese individuals undergoing weight reduction
  839. Obesity and incidence of diabetes: effect of absence of metabolic syndrome, insulin resistance , inflammation and fatty liver .
  840. Construct a rat model of nonalcoholic fatty liver disease with insulin resistance by feeding ruts fat-rich diet
  841. Increased hepatic glucose production and insulin resistance in subjects with non-alcoholic fatty liver disease is associated to increased plasma concentrations of …
  842. Fenretinide ameliorates insulin resistance and fatty liver in obese mice.
  843. Relationship between adiponectin and β-cell function and insulin resistance in female patients with nonalcoholic fatty liver disease
  844. Protective effects of Chaihu Shugan San on nonalcoholic fatty liver disease in rats with insulin resistance .
  845. … between adiponectin and anthropometric parameters, insulin resistance and transaminase levels in patients with nonalcoholic fatty liver disease and type 2 diabetes
  846. The ABCG5 ABCG8 Sterol Transporter Opposes insulin resistance and fatty liver Disease Independent of Phytosterol Accumulation
  847. Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease.
  848. The significance of CK-18 (M30) and insulin resistance index in non-alcoholic fatty liver CT grading detection
  849. Role of Tumor Necrosis Factor-a Promoter Polymorphism and insulin resistance in the Development of Non-alcoholic fatty liver Disease in Obese Children
  850. … training (aerobic interval and resistive) with two intensity on FGF-21, liver enzymes, insulin resistance and body composition in women with non-alcoholic fatty liver
  851. Effect of iron depletion by phlebotomy on insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia; results of a case control study
  852. The role of endothelial lipase in the diagnosis of cardiovascular risk in patients with non-alcoholic fatty liver disease in hypertension and insulin resistance subjects
  853. Mice with insulin resistance and non-alcoholic fatty liver are characterized by cardiac hypertrophy and increased oxidative stress
  854. … fatty liver DISEASE (NAFLD) IN NATIVE VERSUS FOREIGN BLACKS IN THE UNITED STATES: THE ROLE OF ADIPOSITY AND insulin resistance
  855. … P levels are related to adipose tissue insulin resistance , composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic fatty liver Disease
  856. Effect of Glycyrrhizin combined with puerarin on serum leptin and insulin resistance in patients with non-alcoholic fatty liver disease
  857. Early menarche is associated with insulin resistance and non-alcoholic fatty liver disease in obese adolescents
  858. Plasma Branch Chain and Aromatic Amino Acid Levels are Associated with insulin resistance in Nonalcoholic fatty liver Disease (NAFLD)
  859. Hepatic lipid saturation indices and insulin resistance in non‐alcoholic fatty liver disease (NAFLD)
  860. Kukoamine a attenuates insulin resistance and fatty liver through downregulation of Srebp-1c.
  861. Supplementing dietary sugar promotes endoplasmic reticulum stress-independent insulin resistance and fatty liver in goose.
  862. Rising obesity rates boosting liver disease risk: the typical patient with nonalcoholic fatty liver disease has a BMI above 30 and insulin resistance .
  863. … Effect of Polyphenolic Compounds from the Mangrove tree Rhizophora mangle L. Improving Non-Alcoholic fatty liver Disease and insulin resistance in High-Fat …
  864. Non-alcoholic fatty liver Disease (NAFLD) is Exacerbated with TRAIL Deletion, Associating with Vascular Inflammation and insulin resistance
  865. Long-term fermented soybean paste improves metabolic parameters associated with non-alcoholic fatty liver disease and insulin resistance in high-fat diet-induced …
  866. … by liraglutide with intensive lifestyle modification on hepatic steatosis, inflammation and stiffness, and insulin resistance in obese Asians with non-alcoholic fatty liver  …
  867. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
  868. Determinants of insulin resistance and nonalcoholic fatty liver disease (NAFLD) in children
  869. Clinical Study on 29 Cases of Nonalcoholic fatty liver Disease with insulin resistance Treated by Strengthening Spleen, Tonifying Kidney, Invigorating Blood Flow …
  870. … -074 Heme Oxygenase-1 Gene Promoter Polymorphism And insulin resistance Are Associated With Susceptibility To Non-alcoholic fatty liver Disease In Children
  871. Association of serum leptin with insulin resistance in patients with type 2 DM and non-alcoholic fatty liver (NAFL)
  872. Dietary (-)-epigallocatechin-3-gallate supplementation counteracts aging-associated skeletal muscle insulin resistance and fatty liver in senescence-accelerated …
  873. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver .
  874. SAFETY AND EFFICACY OF THE PAN-CASPASE INHIBITOR IDN-6556 ON THE TREATMENT OF NONALCOHOLIC fatty liver AND insulin resistance
  875. … -derived chemotaxin 2 in patients with newly diagnosed type 2 diabetes complicated with non-alcoholic fatty liver disease and its association with insulin resistance
  876. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcholic fatty liver disease and hyperfettitinemia; evidence from a case control study
  877. Specific modulation of hepatic estrogen receptor alpha prevents fatty liver but also obesity and insulin resistance induced by a high fat diet in mice
  878. Iron depletion by phlebotomy improves insulin resistance in patients with non alcoholic fatty liver disease and hyperferritinemia; evidence from a multicenter case …
  879. … of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver :[Eur. J. Pharmacol …
  880. resistance to insulin suppression of plasma free fatty acids in liver cirrhosis
  881. Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats.
  882. Correction: The fatty acid synthase inhibitor platensimycin improves insulin resistance without inducing liver steatosis in mice and monkeys
  883. Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): a Narrative Review
  884. Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis
  885. Relationship of liver Enzymes to Homeostatic Model Assessment insulin resistance in Non-Alcoholic fatty liver Disease Patients: A Meta-Analysis and Systematic …
  886. Metabolic-Associated fatty liver Disease and insulin resistance : A Review of Complex Interlinks
  887. Nonalcoholic fatty liver disease and insulin resistance in children
  888. NADPH oxidases connecting fatty liver disease, insulin resistance and type 2 diabetes: Current knowledge and therapeutic outlook
  889. Dietary and lifestyle indices for insulin resistance and nonalcoholic fatty liver disease
  890. Effect of exercise on liver function and insulin resistance markers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of …
  891. The effect of a fruit-rich diet on liver biomarkers, insulin resistance , and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial
  892. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population
  893. insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
  894. Effect of aerobic exercise alone or in conjunction with diet on liver function, insulin resistance and lipids in non-alcoholic fatty liver disease
  895. Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease
  896. Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance
  897. GLP-1 RAs and SGLT-2 inhibitors for insulin resistance in nonalcoholic fatty liver disease: systematic review and network meta-analysis
  898. … hepatic insulin resistance –hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 …
  899. Metabolic score for insulin resistance is inversely related to incident advanced liver fibrosis in patients with non-alcoholic fatty liver disease
  900. Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance : A systematic review
  901. fatty liver biomarkers and insulin resistance indices in the prediction of non‐alcoholic fatty liver disease in Ghanaian patients
  902. Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: from bench to patient care
  903. Indirect insulin resistance markers are associated with non-alcoholic fatty liver disease in type 1 diabetes
  904. The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults
  905. Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: potential benefits and limitations
  906. Relationship between insulin resistance Risk Scales and Non-Alcoholic fatty liver Disease and liver Fibrosis Scales in 219,477 Spanish Workers
  907. Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational …
  908. Relationship between six insulin resistance surrogates and nonalcoholic fatty liver Disease among older adults: a cross-sectional study
  909. insulin resistance , Non-Alcoholic fatty liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
  910. Increasing risk factors for non-alcoholic fatty liver disease; an insight into chronic periodontitis and insulin resistance
  911. GATA3 as an immunomodulator in obesity-related metabolic dysfunction associated with fatty liver disease, insulin resistance , and type 2 diabetes
  912. The impact of insulin resistance on hepatic fibrosis among United States adults with non-alcoholic fatty liver disease: NHANES 2017 to 2018
  913. Metabolic dysfunction‐associated fatty liver disease directly related to liver fibrosis independent of insulin resistance , hyperlipidemia, and alcohol intake in morbidly …
  914. insulin resistance /Sensitivity Measures as Screening Indicators of Metabolic-Associated fatty liver Disease and liver Fibrosis
  915. Increased let‐7d‐5p in non‐alcoholic fatty liver promotes insulin resistance and is a potential blood biomarker for diagnosis
  916. Prediction and Validation of Metabolic Dysfunction-Associated fatty liver Disease Using insulin resistance -Related Indices in the Japanese Population
  917. Adiponectin–leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance
  918. Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress
  919. Type 2 Diabetes Mellitus and insulin resistance in Nonalcoholic fatty liver Disease
  920. Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie’s disease? A pilot study.
  921. Dose-response associations of metabolic score for insulin resistance index with nonalcoholic fatty liver disease among a nonobese Chinese population …
  922. Effects of folic acid supplementation on liver enzymes, lipid profile, and insulin resistance in patients with non-alcoholic fatty liver disease: A randomized …
  923. RELATION OF insulin resistance IN NON-ALCOHOLIC fatty liver DISEASE
  924. Peripheral blood mononuclear cells‐expressed miRNA profiles derived from children with metabolic‐associated fatty liver disease and insulin resistance
  925. Long-chain saturated fatty acids and its interaction with insulin resistance and the risk of nonalcoholic fatty liver disease in type 2 diabetes in Chinese
  926. Association between remnant cholesterol and insulin resistance levels in patients with metabolic-associated fatty liver disease
  927. insulin resistance Markers to Detect Nonalcoholic fatty liver Disease in a Male Hispanic Population
  928. fatty liver Disease and Its Impaction on insulin resistance
  929. Causal effect of lower birthweight on non‐alcoholic fatty liver disease and mediating roles of insulin resistance and metabolites
  930. Impact of insulin resistance on mild cognitive impairment in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease
  931. Risk Factors for Nonalcoholic fatty liver Disease with Different insulin resistance in a Nonobese Chinese Population
  932. Association Between Visceral Adiposity, insulin resistance , And fatty liver In Patients With Type 2 Diabetes Mellitus
  933. Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes
  934. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance , hyperammonemia, gut dysbiosis, vascular impairment, and inflammation
  935. Impact of COVID-19 lockdown on non-alcoholic fatty liver disease and insulin resistance in adults: a before and after pandemic lockdown longitudinal study
  936. Machine learning-derived gut microbiome signature predicts fatty liver disease in the presence of insulin resistance
  937. Investigating Visfatin gene Polymorphism rs4730153 with insulin resistance and Non-Alcoholic fatty liver Diseases in Iranian Population
  938. Neck Circumference as a Predictor of insulin resistance in People with Non-alcoholic fatty liver Disease
  939. Lipid profile, insulin resistance & non-alcoholic fatty liver disease (NAFLD) among type 2 diabetes patients getting treatment in Jaffna
  940. insulin resistance and metabolism-associated fatty liver disease: Pathways of action of hypoglycemic agents
  941. Diagnostic accuracy of inflammation and insulin resistance markers in non-alcoholic fatty liver disease in children
  942. PREDICTORS FOR insulin resistance IN METABOLIC DYSFUNCTION ASSOCIATED fatty liver DISEASE
  943. Concerning issues in “effect of a fruit rich diet on liver biomarkers, insulin resistance , and lipid profile in patients with non-alcoholic fatty liver disease: a randomized …
  944. Is Homeostasis Model Assessment for insulin resistance > 2.5 a distinguished criteria for metabolic dysfunction-associated fatty liver disease identification?
  945. Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a …
  946. Cyclosorus terminans Extract Ameliorates insulin resistance and Non-Alcoholic fatty liver Disease (NAFLD) in High-Fat Diet (HFD)-Induced Obese Rats
  947. Comparisons of insulin resistance -and steatosis-based scores in monitoring metabolic associated fatty liver disease treatment response
  948. A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice
  949. Inhibition of GPR120 signaling in intestine ameliorates insulin resistance and fatty liver under high-fat diet feeding
  950. Association of ADIPOQ gene variants with adiponectin levels, insulin resistance and non-alcoholic fatty liver disease, in an Iranian population
  951. Metabolic impact of MKP-2 upregulation in obesity promotes insulin resistance and fatty liver disease
  952. … ASSOCIATED (FTO) RS17817449 GENE POLYMORPHISM WITH insulin resistance AND OBESITY IN THE PATIENTS WITH NON-ALCOHOLIC fatty liver  …
  953. Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance , and obesity
  954. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults
  955. Hepatocyte smoothened activity controls susceptibility to insulin resistance and nonalcoholic fatty liver disease
  956. Luteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats via regulation of PI3K/AKT …
  957. Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance , and inflammation in vitro and in vivo
  958. Adipose-derived extracellular vesicles–a novel cross-talk mechanism in insulin resistance , non-alcoholic fatty liver disease, and polycystic ovary syndrome
  959. Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease
  960. A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis
  961. … of Periodontitis Exacerbates Non-Alcoholic fatty liver Disease via Sphingolipid Metabolism-Associated insulin resistance and Hepatic Inflammation in Mice …
  962. Lactobacillus paracasei improves dietary fatty liver by reducing insulin resistance and inflammation in obese mice model
  963. Discovery of JND003 as a new selective estrogen-related receptor α agonist alleviating nonalcoholic fatty liver disease and insulin resistance
  964. KLHL3 deficiency in mice ameliorates obesity, insulin resistance , and nonalcoholic fatty liver disease by regulating energy expenditure
  965. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis
  966. Adiponectin is Inversely Associated with insulin resistance in Adolescents with Nonalcoholic fatty liver Disease
  967. The Metabolic Score for insulin resistance Index is Superior to the Triglyceride and Glucose Index in Identifying Nonalcoholic fatty liver Disease in Hyperuricemia …
  968. S1505 insulin resistance is an Independent Predictor of Non-Alcoholic fatty liver Disease in Lean United States Adults
  969. Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non‐alcoholic fatty liver  …
  970. Swimming exercise ameliorates insulin resistance and nonalcoholic fatty liver by negatively regulating PPARγ transcriptional network in mice fed high fat diet
  971. Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance
  972. … of High Intensity Interval Training and Portulaca Oleracea Supplement on Changes in Fetuin A Level and insulin resistance in Rats with Non-Alcoholic fatty liver  …
  973. Expressing the human cholesteryl ester transfer protein minigene improves diet-induced fatty liver and insulin resistance in female mice
  974. Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 …
  975. … lycopene-loaded nano-liposomes: Alleviating insulin resistance , hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of …
  976. Diet containing dehulled adlay ameliorates hepatic steatosis, inflammation and insulin resistance in rats with non-alcoholic fatty liver disease
  977. Effect of High-Intensity Interval Training and Portulaca Oleracea extract on Sirtuin1 Level and insulin resistance in Rats with Non-Alcoholic fatty liver Disease
  978. Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
  979. Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
  980. Fenofibrate Improves insulin resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic fatty liver  …
  981. Buchholzia coriacea seed (wonderful kolanut) alleviates insulin resistance , steatosis, inflammation and oxidative stress in high fat diet model of fatty liver disease
  982. Comparison of aspartate aminotransferase platelet ratio index score and insulin resistance in type 2 diabetes mellitus with non-alcoholic fatty liver disease
  983. The valine-3-HIB pathway in obesity, insulin resistance and fatty liver
  984. Metabolic dysfunction-associated fatty liver disease in obese youth with insulin resistance and type 2 diabetes
  985. … on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and …
  986. Structurally‐engineered fatty acid 1024 (SEFA‐1024) improves diet‐induced obesity, insulin resistance , and fatty liver disease
  987. Investigation of Non-alcoholic steatohepatitis development in newly designed short-term insulin resistance –fatty liver rat models. From chronic to acute
  988. The effect of fatty liver induction with estradiol injection on expression of insulin resistance -related genes in liver of post-peak laying hens
  989. Peripheral blood mononuclear cells-expressed miRNA profiles derived from children with metabolic-associated fatty liver disease and insulin resistance
  990. The effect of heat‐killed Lactobacillus brevis SBL88 on improving selective hepatic insulin resistance in non‐alcoholic fatty liver disease mice without altering the gut …
  991. … hepatic steatosis and insulin resistance , and alters autophagy and gut microbiota diversity in mouse models of high-fat diet-induced non-alcoholic fatty liver  …
  992. Effects of insulin resistance and Hepatic Fibrosis in Persons with Non-alcoholic fatty liver Disease in North Kerala
  993. … of High-Intensity Interval Training and Portulaca Oleracea Extract Supplementation on FGF-21 Level and insulin resistance in Rats with Non-Alcoholic fatty liver  …
  994. Non-alcoholic fatty liver disease in obese subjects as related to increasing insulin resistance and deteriorating glucose control: Three years of follow-up from a …
  995. Serum interleukin-38 levels correlated with insulin resistance , liver injury and lipids in non-alcoholic fatty liver disease
  996. … IN HEPATIC STEATOSIS, OBESITY, AND insulin –resistance IN ADULTS WITH NON-ALCOHOLIC fatty liver DISEASE UNDERGOING THE PRIMARY …
  997. Reply: Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
  998. Hepatic Lipid Droplet-Associated Proteome Changes Distinguish Dietary-Induced fatty liver from insulin resistance in Male Mice.
  999. Ageing rates and oxidative stress in patients with non-alcoholic fatty liver disease and profound insulin resistance
  1000. Comparisons of insulin resistance -and Steatosis-Based Scores in Monitoring Metabolic Associated fatty liver Disease Treatment
  1001. Egg-white derived bioactive peptides improve insulin resistance and non-alcoholic fatty liver disease in mice: mechanisms of action
  1002. … to the editor about “the effect of a fruit-rich diet on liver biomarkers, insulin resistance , and lipid profile in patients with non-alcoholic fatty liver disease: a randomized …
  1003. Indirect insulin resistance markers in relation to nonalcoholic fatty liver disease among patients with type 1 diabetes mellitus
  1004. Influence of histone deacetylase 1 on insulin resistance in a cell model of nonalcoholic fatty liver disease
  1005. TyG index correlation with surrogate measures of visceral obesity, insulin resistance and non-alcoholic fatty liver disease
  1006. The role of pioglitazone in the fight against insulin resistance , atherosclerosis, cardiovascular disease, and non-alcoholic fatty liver disease
  1007. 294-OR: Hepatic Integrin ß1 Subunit Is Required for liver insulin resistance but Not fatty liver in Diet-Induced Obese Mice
  1008. ASSOCIATION OF RETN GENE POLYMORPHISM WITH SERUM RESISTIN LEVEL, insulin resistance , AND NON-ALCOHOLIC fatty liver DISEASE IN AN …
  1009. … monocyte to high-density lipoprotein cholesterol ratio and insulin resistance in male patients with type 2 diabetes mellitus combined with metabolic-related fatty liver  …
  1010. The effect of high intensity interval training on serum levels of fibroblast growth factor 21, liver enzymes, lipid profile and insulin resistance in women with fatty liver
  1011. … training with Portulaca oleracea Hydroalcoholicextract on gene expression of Selenoprotein P (SeP) and insulin resistance in rats with nonalcoholic fatty liver
  1012. … Glucose Index Is Superior To The Homeostasis Model Assessment Of insulin resistance For Predicting Severity Of Nonalcoholic fatty liver Disease In Korean …
  1013. The Relationship between insulin resistance and fatty liver in Early Lactation Dairy Cows
  1014. Exploring Acupuncture for Non-Alcoholic fatty liver Based on insulin resistance
  1015. Mediating effect of leptin levels between insulin resistance and nonalcoholic fatty liver disease in obese children
  1016. Peripheral insulin resistance Predicts liver Damage in Non-Diabetic Subjects with Non Alcoholic fatty liver Disease
  1017. … Platelet Distribution Width (PDW), Red Blood Cell Distribution Width (RDW), and insulin resistance in People With Type 2 Diabetes and Nonalcoholic fatty liver  …
  1018. Crosstalk between adipose tissue insulin resistance and liver macrophage activation in patients with Non-Alcoholic fatty liver Disease
  1019. Validating Rat Model of Polycystic Ovary Syndrome Induced Non-Alcoholic fatty liver Disease: Role of Hyperandrogenism and insulin resistance
  1020. Changes in Chemerin Level And insulin resistance in Rats With Non-Alcoholic fatty liver Disease: Effect of High Intensity Interval Training and Portulaca Oleracea …
  1021. Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance : a systematic review
  1022. S1321 Homeostasis Model Assessment of insulin resistance as a Clinical Marker of Non-Alcoholic fatty liver Disease in Lean Individuals
  1023. Hepatic insulin resistance is the basis of bile acid dysmetabolism in non-alcoholic fatty liver disease
  1024. … on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
  1025. Investigating the Intertwine Effect of insulin resistance and Lipocalin Prostaglandin D2 Synthase in Non-alcoholic fatty liver Disease using HepG2 Cells
  1026. Response-to Letter-to-the-editor:” A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice.”
  1027. Hepatic insulin resistance Drives Visceral Obesity and Non-Alcoholic fatty liver Disease
  1028. … adiponectin, homeostatic model assessment insulin resistance index and their ratio and liver fibrosis in newly diagnosed diabetic patients with nonalcoholic fatty liver  …
  1029. … AND ASSOCIATED FACTORS OF insulin resistance AMONG NON-DIABETIC PATIENTS WITH NON-ALCOHOLIC fatty liver DISEASE USING HOMA …
  1030. 100-OR: Association of Recent Myocardial Infarction with insulin resistance and fatty liver Disease in Type 2 Diabetes
  1031. THU312 The Type 1 Diabetes Susceptible LEW. 1WR1 Rat Develops insulin resistance And Severe Non-alcoholic fatty liver Disease
  1032. The association between non-alcoholic fatty liver disease and insulin resistance within normal glucose level population
  1033. Changes in Angiopoietin-like 4 Protein Level and insulin resistance in Rats with Non-Alcoholic fatty liver Disease: Effect of High Intensity Interval Training and …
  1034. Sex Hormone Binding Globulin (SHBG)-A Potential Biomarker for insulin resistance , Non-Alcoholic fatty liver and Hepatic Lipogenesis
  1035. 8-OR: Plasminogen Deficiency Protects against Nonalcoholic fatty liver Disease and insulin resistance , but Not Diet-Induced Obesity
  1036. … C-peptide in Conjunction with the insulin resistance Index for Assessing Hepatic Fibrosis in Patients with Type 2 Diabetes Mellitus and Nonalcoholic fatty liver  …
Related Posts

Protein Carbonylation

Phenylpropanoids

Cold-inducible Rna-binding Protein (Cirbp) & Dna Repair

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping